Abiopharma

SYNOPSYS INC (SNPS)

Symbol	SNPS
Name	SYNOPSYS INC
Sector	TECHNOLOGY
Region	North America
Industry	Services-Prepackaged Software
Address	675 ALMANOR AVE, SUNNYVALE, CA 94085
Telephone	6505845000
Fax	—
Email	—
Website	https://www.synopsys.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0000883241
Description	Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firms growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys. Additional info from NASDAQ: Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firms growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.

2026-08-31 22:40

Director DE GEUS AART 🟡 adjusted position in 25.0K shares (1 derivative) of SYNOPSYS INC (SNPS) at $445.55 ($17.9M) Transaction Date: Aug 28, 2026 | Filing ID: 000008

2026-08-28 20:14

📋 DE GEUS AART (Officer) plans to sell 75K shares of SYNOPSYS INC (at $461.85 each, total $34.5M) Filed: Aug 28, 2026 | ID: 000965

2026-08-26 20:05

Synopsys Posts Financial Results for Third Quarter Fiscal Year 2026

2026-08-17 22:14

LEE JANET 🟡 adjusted position in 318 shares (1 derivative) of SYNOPSYS INC (SNPS) at $421.50 Transaction Date: Aug 16, 2026 | Filing ID: 000020

2026-08-12 13:15

(99% Neutral) SYNOPSYS INC (SNPS) Announces New Board Appointment

2026-06-16 21:12

LEE JANET 🟡 adjusted position in 235 shares (1 derivative) of SYNOPSYS INC (SNPS) at $454.38 Transaction Date: Jun 15, 2026 | Filing ID: 000018

2026-06-16 21:07

Kankanwadi Sudhindra 🟡 adjusted position in 249 shares (1 derivative) of SYNOPSYS INC (SNPS) at $454.38 Transaction Date: Jun 15, 2026 | Filing ID: 000006

2026-06-16 21:00

Glaser Shelagh 🟡 adjusted position in 436 shares (1 derivative) of SYNOPSYS INC (SNPS) at $454.38 Transaction Date: Jun 15, 2026 | Filing ID: 000012

2026-06-16 20:56

Director Ghazi Sassine 🟡 adjusted position in 16.1K shares (2 derivative) of SYNOPSYS INC (SNPS) at $458.96 ($11.3M) Transaction Date: Jun 15, 2026 | Filing ID: 000006

2026-06-16 20:52

Director DE GEUS AART 🟡 adjusted position in 156 shares (1 derivative) of SYNOPSYS INC (SNPS) at $454.38 Transaction Date: Jun 15, 2026 | Filing ID: 000006